Europe News
Filter News
Found 88,729 articles
-
More than 150 countries have signed on to a World Health Organization program to ensure global access to a COVID-19 vaccine, however, the United States, Russia and China refrained from signing the agreement.
-
Bristol Myers Squibb and bluebird bio are eying a potential quick approval for a CAR-T treatment for multiple myeloma after the U.S. Food and Drug Administration accepted the Biologics License Application under priority review.
-
Tagrisso demonstrated an 82% reduction in the risk of central nervous system recurrence or death. The safety and tolerability of the product in the Phase III trial was consistent with previous trials in the metastatic EGFRm NSCLC setting.
-
Debiopharm Honored as a 2020 Swiss Biotech Success Story Winner For Outstanding Achievements Over 40 Years
9/22/2020
Debiopharm, ( www.debiopharm.com ), a Swiss-based biopharmaceutical company today announced being one of the recipients of the 2020 Swiss Biotech Success Story Award for exceptional achievements in the biotech industry. Every year, the Swiss Biotech Association awards companies or individuals within the biotech sector i
-
Medtronic Receives FDA "Breakthrough Device Designation" for TYRX Driveline Wrap Device
9/22/2020
Medtronic plc (NYSE:MDT), the global leader in medical technology, has received Breakthrough Device Designation status from the U.S. Food and Drug Administration (FDA) for the TYRX™ Absorbable Antibacterial Driveline Wrap, which is intended to securely hold a percutaneous driveline in patients receiving a ventricular assist device (VAD).
-
Oxford Immunotec Joins Forces with Public Health England (PHE) in a Large Clinical Trial Utilizing T-SPOT® Discovery™ SARS-CoV-2 Test
9/22/2020
Oxford Immunotec Global PLC (Nasdaq: OXFD) (the “Company”), a global, high-growth diagnostics company, today announced that it has entered into an extensive research collaboration with Public Health England (PHE), an executive agency of the UK’s Department for Health and Social Care (DHSC). As part of this, PHE has launched the ‘Evaluating Detection of SARS-CoV-2 antibodies using home test kits’ study (EDSAB-HOME
-
CRISPR Therapeutics and Vertex Pharmaceuticals Announce Priority Medicines (PRIME) Designation Granted by the European Medicines Agency (EMA) to CTX001™ for the Treatment of Sickle Cell Disease
9/22/2020
CRISPR Therapeutics (Nasdaq: CRSP) and Vertex Pharmaceuticals Inco r porated (Nasdaq: VRTX) today announced the European Medicines Agency (EMA) has granted Priority Medicines (PRIME) designation to CTX001, an investigational, autologous, ex vivo CRISPR/Cas9 gene-edited therapy for the treatment of severe sickle cell disease (SCD). PRIME is a regulatory mechanism that provides early and proactive supp
-
Jennewein Biotechnologie GmbH and Chr. Hansen A/S to join forces in high-growth Human Milk Oligosaccharides market
9/22/2020
Jennewein Biotechnologie GmbH agreed to join forces with Chr. Hansen Holding A/S, a leading bioscience company based in Hoersholm/ Denmark , to lead the global market for human milk oligosaccharides (HMOs). Chr. Hansen entered into an agreement to acquire all shares in Jennewein Biotechnologie, the innovation a
-
Oculis to present significant corporate and clinical development progress at upcoming biotech and ophthalmology conferences
9/22/2020
Oculis S.A., a biopharmaceutical company focused on developing transformative topical ophthalmic treatments to improve the sight and lives of patients, announced that Dr. Marcia de Souza Lima, Chief Medical Officer, will present at a number of upcoming virtual industry conferences – see below.
-
Congenica Launches New Host Genetics Module to Advance COVID-19 Research
9/22/2020
Congenica, a digital health company enabling rapid and accurate analysis of complex genomic data, has launched a new module for its genomic analysis platform that will accelerate research into the relationship between an individual's genomic variation and COVID-19 susceptibility, severity, and clinical outcomes.
-
AI in Medical Imaging to Reach $1.5 Billion by 2024
9/22/2020
The world market for AI-based clinical applications for use in medical imaging is set to reach almost $1.5 billion by 2024 despite a slower-than-expected uptake of these products and the impact of the COVID-19 pandemic.
-
Geometric Medical Announces Rebranding and Launch of New Website
9/22/2020
Geometric Medical, a global-leading high-end medical animation and scientific video production company, unveils its company rebranding and has launched its new, full-featured website www.geometricmedical.com
-
OXGENE Introduces TESSA Technology for Robust and Reproducible AAV Manufacture at Scale
9/22/2020
Novel, plasmid-free manufacturing system reduces cost of goods and improves AAV quality to enable development of safer gene therapies
-
ERS Genomics Appoints Michael Arciero as Vice-President of Intellectual Property & Commercial Development
9/22/2020
ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, announced the appointment of Michael Arciero as Vice-President of Intellectual Property and Commercial Development.
-
Synaffix Wins Best Platform Technology at 7th Annual World ADC Awards
9/22/2020
Synaffix B.V., a biotechnology company enabling antibody-drug conjugates with best-in-class therapeutic index, announces that it has won the “Best ADC Platform Technology” category at the 2020 World ADC Awards ceremony.
-
Micreos initiates clinical trial to evaluate world's first endolysin-drug as a therapy for Atopic Dermatitis
9/22/2020
Dutch biotech company Micreos Human Health has enrolled the first patients in a Phase I/IIa, randomized, double-blind, placebo-controlled, parallel treated dose-ranging study to assess the safety and efficacy of XZ.700 in patients with mild to moderate atopic dermatitis.
-
Enterome to Present at Jefferies Virtual Next Generation IBD Therapeutics Summit
9/22/2020
ENTEROME SA announces that Pierre Belichard, Chief Executive Officer, and Christophe Bonny, Chief Scientific Officer, will present at the Jefferies Virtual Next Generation IBD Therapeutics Summit, which will take place September 23-24, 2020.
-
Gyroscope Therapeutics Granted FDA Fast Track Designation for GT005, an Investigational Gene Therapy for Dry Age-Related Macular Degeneration
9/22/2020
Gyroscope Therapeutics Limited, a clinical-stage retinal gene therapy company, announced that the U.S. Food and Drug Administration has granted Fast Track designation to GT005 for the treatment of geographic atrophy secondary to dry age-related macular degeneration.
-
Europital launches as science-driven full service CRO
9/22/2020
The expanded clinical research offering will see Europital support clients as a full service CRO in over 40 countries from IND through to commercial launch.
-
Swiss pharma giant Roche acquired Ireland’s Inflazome and its NLRP3 inflammasome inhibitors aimed at multiple inflammatory diseases for €380 million (about $451 million) in an upfront payment.